YMN-A02 for Advanced Primary Hepatocellular Carcinoma.
NCT07580261
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
YMN-A02 100μg
BIOLOGICAL:
YMN-A02 250μg
BIOLOGICAL:
YMN-A02 500μg
BIOLOGICAL:
YMN-A02 1000μg
Sponsor
West China Hospital